Literature DB >> 15512265

Self-assessment of morbidity following radical hysterectomy for cervical cancer.

S A Butler-Manuel1, K Summerville, A Ford, P Blake, A J Riley, A H Sultan, A K Monga, S L Stanton, J H Shepherd, D P Barton.   

Abstract

The aim of this study was to assess the magnitude of the morbidity following radical surgery for early stage cervical cancer. We performed a retrospective survey of all women who had undergone a radical hysterectomy and lymphadenectomy between the months of July 1995 and December 1996 inclusive at either the Royal Marsden or St George's Hospital (n =38), using a detailed questionnaire on bladder, ano-rectal and sexual function, both before and after treatment. Sixteen women (44.4%) received adjuvant radiotherapy. The mean interval between surgery and inquiry was 16.4% months (range 8-25 months). The mean age at the time of surgery was 40.5 years. Thirty-six out of 38 women contacted responded (94.7%). Overall 33 women (91.7%) reported new bladder, ano-rectal or sexual symptoms. Complaints of urinary incontinence, particularly of urge incontinence, and of voiding difficulties increased significantly after surgery (P <0.05). However, only 5.3% of women had sought treatment. Tenesmus increased significantly (P <0.05), while increases in diarrhoea and faecal incontinence were not statistically significant (P =0.051). Although 12.9% of women stated an improvement in their sex lives, 54.8% thought that their sex life was worse after treatment, and 12.9% of women had ceased sexual activity altogether. Of women of childbearing age 53.8% felt adversely affected by their loss of fertility. Bladder, ano-rectal and sexual symptoms are very common following radical hysterectomy for cervical cancer, with adverse effect on quality of life, and persist into the second year after treatment.

Entities:  

Year:  1999        PMID: 15512265     DOI: 10.1080/01443619965552

Source DB:  PubMed          Journal:  J Obstet Gynaecol        ISSN: 0144-3615            Impact factor:   1.246


  6 in total

1.  Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse.

Authors:  Åsa H Everhov; Sara Ekberg; Angelica Lindén Hirschberg; Karin Bergmark; Angelique Flöter Rådestad; Ingrid Glimelius; Karin E Smedby
Journal:  J Cancer Surviv       Date:  2015-11-12       Impact factor: 4.442

2.  A multi-institutional survey of the quality of life after treatment for uterine cervical cancer: a comparison between radical radiotherapy and surgery in Japan.

Authors:  Yuko Kaneyasu; Hisaya Fujiwara; Tetsuo Nishimura; Hideyuki Sakurai; Tomoko Kazumoto; Hitoshi Ikushima; Takashi Uno; Sunao Tokumaru; Yoko Harima; Hiromichi Gomi; Takafumi Toita; Midori Kita; Shin-Ei Noda; Takeo Takahashi; Shingo Kato; Ayako Ohkawa; Akiko Tozawa-Ono; Hiroki Ushijima; Yoko Hasumi; Yasuyuki Hirashima; Yuzuru Niibe; Tomio Nakagawa; Tomoyuki Akita; Junko Tanaka; Tatsuya Ohno
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

3.  ACCEPTANCE: protocol for a feasibility study of a multicomponent physical activity intervention following treatment for cervical cancer.

Authors:  Nessa Millet; Hilary J McDermott; Fehmidah Munir; Charlotte L Edwardson; Esther L Moss
Journal:  BMJ Open       Date:  2022-01-03       Impact factor: 2.692

Review 4.  Body Image, Sexuality, and Sexual Functioning in Women With Gynecologic Cancer: An Integrative Review of the Literature and Implications for Research.

Authors:  Christina M Wilson; Deborah B McGuire; Beth L Rodgers; R K Elswick; Sarah M Temkin
Journal:  Cancer Nurs       Date:  2021 Sep-Oct 01       Impact factor: 2.592

5.  Predicting factors for resumption of spontaneous voiding following nerve-sparing radical hysterectomy.

Authors:  Chalaithorn Nantasupha; Kittipat Charoenkwan
Journal:  J Gynecol Oncol       Date:  2018-04-23       Impact factor: 4.401

Review 6.  Comprehensive Review of the Cardinal Ligament.

Authors:  Seif Eid; Joe Iwanaga; Rod J Oskouian; Marios Loukas; R Shane Tubbs
Journal:  Cureus       Date:  2018-06-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.